批准日期，申请提交历史，通知信，药品说明书，审评文件等信息
| 提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级；罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
|---|
| 2014/02/19 |
SUPPL-5（补充） |
Approval |
Manufacturing (CMC) |
|
|
|
| 2002/11/04 |
SUPPL-3（补充） |
Approval |
Labeling |
|
|
|
| 2001/06/22 |
SUPPL-1（补充） |
Approval |
Manufacturing (CMC) |
|
|
|
| 1998/11/25 |
ORIG-1（原始申请） |
Approval |
|
|
|
|
与本品相关的专利信息（来自FDA橙皮书Orange Book）
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
|---|
| 无 |
与本品治疗等效的药品
活性成分:GUANFACINE HYDROCHLORIDE 剂型/给药途径:TABLET;ORAL 规格:EQ 1MG BASE 治疗等效代码:AB
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
|---|
| 074145 |
001 |
ANDA |
GUANFACINE HYDROCHLORIDE |
GUANFACINE HYDROCHLORIDE |
TABLET;ORAL |
EQ 1MG BASE |
Prescription |
No |
No |
AB |
1995/10/17
|
WATSON LABS |
| 074796 |
001 |
ANDA |
GUANFACINE HYDROCHLORIDE |
GUANFACINE HYDROCHLORIDE |
TABLET;ORAL |
EQ 1MG BASE |
Prescription |
No |
No |
AB |
1997/01/27
|
AUROBINDO PHARMA USA |
| 074673 |
001 |
ANDA |
GUANFACINE HYDROCHLORIDE |
GUANFACINE HYDROCHLORIDE |
TABLET;ORAL |
EQ 1MG BASE |
Prescription |
No |
No |
AB |
1997/02/28
|
EPIC PHARMA LLC |
| 075109 |
001 |
ANDA |
GUANFACINE HYDROCHLORIDE |
GUANFACINE HYDROCHLORIDE |
TABLET;ORAL |
EQ 1MG BASE |
Prescription |
No |
No |
AB |
1998/11/25
|
AMNEAL PHARM |
| 214689 |
001 |
ANDA |
GUANFACINE HYDROCHLORIDE |
GUANFACINE HYDROCHLORIDE |
TABLET;ORAL |
EQ 1MG BASE |
Prescription |
No |
No |
AB |
2021/03/03
|
UNICHEM |
| 216399 |
001 |
ANDA |
GUANFACINE HYDROCHLORIDE |
GUANFACINE HYDROCHLORIDE |
TABLET;ORAL |
EQ 1MG BASE |
Prescription |
No |
No |
AB |
2022/06/08
|
TWI PHARMS |
| 217293 |
001 |
ANDA |
GUANFACINE HYDROCHLORIDE |
GUANFACINE HYDROCHLORIDE |
TABLET;ORAL |
EQ 1MG BASE |
Prescription |
No |
No |
AB |
2023/04/27
|
AJANTA PHARMA LTD |
| 216828 |
001 |
ANDA |
GUANFACINE HYDROCHLORIDE |
GUANFACINE HYDROCHLORIDE |
TABLET;ORAL |
EQ 1MG BASE |
Prescription |
No |
No |
AB |
2023/10/05
|
I 3 PHARMS |
| 216762 |
001 |
ANDA |
GUANFACINE HYDROCHLORIDE |
GUANFACINE HYDROCHLORIDE |
TABLET;ORAL |
EQ 1MG BASE |
Prescription |
No |
No |
AB |
2023/10/17
|
RUBICON |
| 218326 |
001 |
ANDA |
GUANFACINE HYDROCHLORIDE |
GUANFACINE HYDROCHLORIDE |
TABLET;ORAL |
EQ 1MG BASE |
Prescription |
No |
No |
AB |
2024/02/23
|
XIROMED |
活性成分:GUANFACINE HYDROCHLORIDE 剂型/给药途径:TABLET;ORAL 规格:EQ 2MG BASE 治疗等效代码:AB
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
|---|
| 074145 |
002 |
ANDA |
GUANFACINE HYDROCHLORIDE |
GUANFACINE HYDROCHLORIDE |
TABLET;ORAL |
EQ 2MG BASE |
Prescription |
No |
No |
AB |
1995/10/17
|
WATSON LABS |
| 074796 |
002 |
ANDA |
GUANFACINE HYDROCHLORIDE |
GUANFACINE HYDROCHLORIDE |
TABLET;ORAL |
EQ 2MG BASE |
Prescription |
No |
No |
AB |
1997/01/27
|
AUROBINDO PHARMA USA |
| 074673 |
002 |
ANDA |
GUANFACINE HYDROCHLORIDE |
GUANFACINE HYDROCHLORIDE |
TABLET;ORAL |
EQ 2MG BASE |
Prescription |
No |
No |
AB |
1997/02/28
|
EPIC PHARMA LLC |
| 075109 |
002 |
ANDA |
GUANFACINE HYDROCHLORIDE |
GUANFACINE HYDROCHLORIDE |
TABLET;ORAL |
EQ 2MG BASE |
Prescription |
No |
Yes |
AB |
1998/11/25
|
AMNEAL PHARM |
| 214689 |
002 |
ANDA |
GUANFACINE HYDROCHLORIDE |
GUANFACINE HYDROCHLORIDE |
TABLET;ORAL |
EQ 2MG BASE |
Prescription |
No |
No |
AB |
2021/03/03
|
UNICHEM |
| 216399 |
002 |
ANDA |
GUANFACINE HYDROCHLORIDE |
GUANFACINE HYDROCHLORIDE |
TABLET;ORAL |
EQ 2MG BASE |
Prescription |
No |
No |
AB |
2022/06/08
|
TWI PHARMS |
| 217293 |
002 |
ANDA |
GUANFACINE HYDROCHLORIDE |
GUANFACINE HYDROCHLORIDE |
TABLET;ORAL |
EQ 2MG BASE |
Prescription |
No |
No |
AB |
2023/04/27
|
AJANTA PHARMA LTD |
| 216828 |
002 |
ANDA |
GUANFACINE HYDROCHLORIDE |
GUANFACINE HYDROCHLORIDE |
TABLET;ORAL |
EQ 2MG BASE |
Prescription |
No |
No |
AB |
2023/10/05
|
I 3 PHARMS |
| 216762 |
002 |
ANDA |
GUANFACINE HYDROCHLORIDE |
GUANFACINE HYDROCHLORIDE |
TABLET;ORAL |
EQ 2MG BASE |
Prescription |
No |
No |
AB |
2023/10/17
|
RUBICON |
| 218326 |
002 |
ANDA |
GUANFACINE HYDROCHLORIDE |
GUANFACINE HYDROCHLORIDE |
TABLET;ORAL |
EQ 2MG BASE |
Prescription |
No |
No |
AB |
2024/02/23
|
XIROMED |